Cargando…
Regulation of HTLV-1 transformation
Human T-cell leukemia virus type 1 (HTLV-1) is the only identified oncogenic human retrovirus. HTLV-1 infects approximately 5–10 million people worldwide and is the infectious cause of adult T-cell leukemia/lymphoma (ATL) and several chronic inflammatory diseases, including HTLV-1-associated myelopa...
Autores principales: | Ernzen, Kyle J., Panfil, Amanda R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919135/ https://www.ncbi.nlm.nih.gov/pubmed/35169839 http://dx.doi.org/10.1042/BSR20211921 |
Ejemplares similares
-
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo
por: Ernzen, Kyle, et al.
Publicado: (2023) -
Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Kodama, Daisuke, et al.
Publicado: (2021) -
Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2
por: Lin, Edward, et al.
Publicado: (2022) -
Functional comparison of the HTLV-1 and HTLV-2 antisense viral proteins: implications for pathogenesis
por: Panfil, Amanda R, et al.
Publicado: (2015) -
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1
por: Rodino, Kyle G., et al.
Publicado: (2022)